Products

FluChip-8G Influenza A+B Assay
InDevR
Lab & Diagnostics

See all 1 product →

About InDevR

InDevR is a life sciences tools company that specializes in advanced analytical technologies for the vaccine and biotherapeutics markets. The company develops and manufactures innovative instruments and consumable assay kits designed to accelerate vaccine and biotherapeutic development and production. Their flagship product line, VaxArray®, is a microarray-based system for multiplexed quantification of critical quality attributes such as protein concentration and potency. This platform offers specific kits for various vaccines, including influenza, measles, rubella, polio, and pneumococcal, as well as for mRNA-based therapeutics. InDevR also offers the CypherOne system for automated hemagglutination assays, supporting quality control across diverse vaccine types, including mRNA, protein-based, and viral vectors.

InDevR’s technologies are crucial for physicians and researchers involved in vaccine development and biopharmaceutical manufacturing. The VaxArray platform, for instance, allows for rapid, multiplexed potency assays, combining multiple tests into one to assess antigen integrity, potency, capping efficiency, and intactness, significantly faster than traditional methods. This is vital for R&D, clinical trials, and release testing. The company’s focus on ease of use, standardization, and automation, including 21 CFR Part 11-compliant software and off-the-shelf/custom kits, aims to reduce user error and ensure consistency across different sites, supporting global quality initiatives. InDevR also provides expert services, offering custom assay development, contract multiplex testing, and specialized vaccine testing services to address development bottlenecks and accelerate analysis and validation of vaccines and biotherapeutics. They are a wholly owned affiliate of SSI Diagnostica A/S.

Focus Areas

analytical technologies vaccine development biotherapeutics quality control immunoassay viral quantification mRNA therapeutics microarray technology digital imaging automated assay interpretation

Business Intelligence

TechnologyVaxArray® platform (microarray-based system for multiplexed quantification), CypherOne system (digital imaging and automated interpretation of hemagglutination assays)

What Physicians Need to Know

Analytical Technologies for Vaccine & Biotherapeutic Markets
InDevR specializes in advanced analytical technologies that accelerate the development and manufacturing of vaccines and biotherapeutics. Their VaxArray platform offers multiplexed potency assays, which are crucial for vaccine characterization and quality control. [1, 9, 10, 11, 12] They provide solutions for all stages of vaccine development, from bioprocess optimization to preclinical and clinical testing. [13] This includes identifying and quantifying vaccine antigens in crude sample materials and enabling rapid, sensitive, and precise quantification of antibody levels in clinical serum samples. [13]
Microarray-Based Multiplex Immunoassays
InDevR develops microarray-based multiplex immunoassay instruments, assay kits, and contract assay services. [1] Their VaxArray platform is a microscale, multiplexed, microarray-based immunoassay platform that has been validated for influenza vaccine antigen characterization and adapted for serological analysis of coronaviruses. [2] This technology allows for simultaneous analysis of multiple antigens or antibodies in a single, rapid assay, significantly reducing testing times compared to traditional methods like ELISA. [2, 4, 6, 7]
Fluorescence Imaging & Automated Image Analysis
The company offers benchtop multiplex testing platforms with automated imaging and data analysis. [1] Their CypherOne system provides digital imaging and algorithmic interpretation of hemagglutination and hemagglutination-inhibition assays, complete with auditable electronic records and data export capabilities. [1] This automation streamlines workflows and improves standardization. [3, 4]
Machine Learning for Image-Based Titer Interpretation
InDevR incorporates machine learning for image-based titer interpretation, enhancing the accuracy and efficiency of their analytical platforms. [1]
LNP-Compatible mRNA Capture & Detection Assays
InDevR has developed microarray-based assays for mRNA intactness and 5' capping efficiency. [1] These assays can quantify the proportion of intact, capped mRNA in naked or LNP-encapsulated samples with rapid turnaround, without the need for extraction or amplification. [1, 7, 15] This is particularly relevant for the emerging class of RNA-based therapeutics that rely on lipid nanoparticle (LNP)-encapsulated mRNA for delivery. [17, 18, 19, 20]
Monoclonal Antibody Capture Arrays for Polysaccharide & Protein Antigens
They offer monoclonal antibody capture arrays for both polysaccharide and protein antigens, enabling the detection and quantification of mixtures of multiple proteins, including vaccine antigens, and highly valent mixtures of pneumococcal polysaccharides and conjugate antigens. [7]
Multiplex Serology Assays
InDevR provides multiplex serology assays, which allow for the quantification of multivalent vaccine-induced antibody levels in serum. [7] Their VaxArray platform has been adapted for serological analysis of coronaviruses, enabling simultaneous analysis of antibody responses to multiple antigens in a single assay. [2]
Custom Assay Development & Contract Multiplex Testing Services
InDevR offers custom assay development and expert services, including tailored design, optimization, validation, and transfer of multiplex immunoassays. [1, 7] They also provide contract multiplex testing services for antigen, antibody, and mRNA characterization. [1]
Regulated Assay Kit Production (ISO 13485)
InDevR is ISO 13485 certified for the design, development, manufacture, and service of assays, instrumentation, and in vitro diagnostic devices. [1, 5] This certification ensures a high level of quality management throughout the product lifecycle, confirming their commitment to producing safe and effective products. [5, 21, 22, 23, 27]
Physician Tip

For physicians, InDevR's technologies, particularly their multiplexed assays, offer significant advantages in diagnostics and patient management. The ability to simultaneously test for multiple antigens or antibodies can lead to faster and more comprehensive diagnostic results, potentially reducing the time to diagnosis and treatment initiation. [2, 4, 6, 7] For example, their FluChip-8G™ IVD product aims to enable physicians to identify seasonal influenza viruses and distinguish them from novel potentially pandemic influenza viruses. [5] The rapid turnaround times for assays, such as the VaxArray Polio Assay Kit which quantifies all three poliovirus serotypes in less than 3 hours, can be critical in situations requiring quick decisions. [6] Furthermore, the ISO 13485 certification for their assay kit production ensures that the diagnostic tools physicians use meet international quality standards, contributing to reliable and accurate patient care. [5, 21, 22, 23, 27] While InDevR primarily focuses on the analytical tools for vaccine and biotherapeutic development, the underlying technologies can translate to improved diagnostic capabilities that directly benefit patient care by providing more efficient and accurate information for clinical decision-making. Physicians in specialties like infectious disease, immunology, and public health could particularly benefit from the rapid, multiplexed testing capabilities for disease surveillance, outbreak response, and monitoring vaccine efficacy. [2, 13]

InDevR's systems are designed with laboratory information system (LIS) integration and 21 CFR Part 11-compatible data handling, facilitating seamless integration into existing laboratory workflows and ensuring data integrity and compliance. [1, 3, 4, 7]

Products by InDevR

1 product in the directory

FluChip-8G Influenza A+B Assay
InDevR
Lab & Diagnostics

Videos

News, demos, and interviews about InDevR.

Loading videos...

Videos load interactively. If none appear, search YouTube for InDevR →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

InDevR specializes in microarray-based multiplex immunoassays, fluorescence imaging, and automated image analysis. These technologies are crucial for efficiently characterizing vaccines and biotherapeutics, providing high-throughput data on immune responses and product quality. They also offer LNP-compatible mRNA capture and detection assays, and monoclonal antibody capture arrays for various antigens.
InDevR employs machine learning for image-based titer interpretation, which enhances the accuracy and consistency of results by automating complex data analysis. Their commitment to quality is further demonstrated by their ISO 13485 certification for regulated assay kit production, ensuring their products meet stringent international standards for medical devices.
Yes, InDevR offers custom assay development services, allowing for tailored solutions to meet specific research or diagnostic requirements. They also provide contract multiplex testing services, enabling clients to leverage InDevR's expertise and technology without needing to establish in-house capabilities.
While the specific details of support and training programs aren't explicitly listed, InDevR's focus on complex analytical technologies suggests a commitment to ensuring customer success. Typically, companies in this space offer technical support, application specialists, and training to facilitate the effective use of their platforms and assays.
InDevR's technologies, such as fluorescence imaging and automated image analysis, are designed to streamline laboratory workflows by providing efficient and high-throughput analytical capabilities. Their microarray-based assays offer multiplexing advantages, allowing for the simultaneous detection of multiple analytes, which can optimize resource utilization and reduce turnaround times in a healthcare setting.
The provided information does not detail InDevR's specific pricing models, volume discounts, or partnership options. For such inquiries, it would be best to directly contact InDevR's sales or business development department to discuss customized solutions and pricing structures.

Related Companies

PathologyAILab offers advanced digital cytology services, leveraging a multi-agent AI system for cervical cancer diagnosis. This innovative solution provides comprehensive image analysis to deliver precise and reliable diagnostic insights to healthcare professionals. The service aims to provide rapid results, typically within 2-4 hours, for urgent cases, enabling timely clinical decisions. The process involves submitting digital […]

Ottobock Healthcare Products, an international company based in Duderstadt, Germany, is a global leader in orthopedic technology, specializing in prosthetics, orthotics, wheelchairs, and exoskeletons. Founded in 1919, the company’s mission is to restore and improve independence for individuals with mobility challenges through technological innovation, advanced biomechanics, and advancements in neuromobility. They offer a comprehensive portfolio […]

Bonraybio Co., Ltd. (stock code: 6955) is dedicated to advancing medical innovation and focusing on health, aiming to enhance global medical quality in the reproductive field. The company specializes in providing comprehensive solutions for male infertility, recognizing the increasing challenges posed by aging populations and rising infertility rates worldwide. Their mission is to address the […]

Vitestro is a healthcare AI company that has developed Aletta®, the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). This device automates the diagnostic blood collection process, aiming to set a new standard for blood collection. Vitestro’s technology is designed to address global challenges in manual phlebotomy, such as staffing constraints, heavy workloads, and variability in […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.